PubMed=12801524; DOI=10.1016/S0145-2126(02)00343-0
Kirshenbaum A.S., Akin C., Wu Y.-L., Rottem M., Goff J.P., Beaven M.A., Rao V.K., Metcalfe D.D.
Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.
Leuk. Res. 27:677-682(2003)

DOI=10.1016/j.jaci.2013.12.226
Kirshenbaum A.S., Petrik A., Walsh R., Vepa S., Metcalfe D.D.
Worldwide impact Of LAD2 mast cell line on mast cell biology research.
J. Allergy Clin. Immunol. 133 Suppl. 1:AB57-AB57(2014)

PubMed=25149487; DOI=10.1007/978-1-4939-1173-8_8
Passante E.
Mast cell and basophil cell lines: a compendium.
Methods Mol. Biol. 1192:101-113(2014)

PubMed=25195635; DOI=10.1159/000365729; PMCID=PMC4201868
Kirshenbaum A.S., Petrik A., Walsh R., Kirby T.L., Vepa S., Wangsa D., Ried T., Metcalfe D.D.
A ten-year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line.
Int. Arch. Allergy Immunol. 164:265-270(2014)

DOI=10.1016/j.jaci.2018.12.550
Kirshenbaum A.S., Yin Y., Sundstrom J.B., Bandara G., Metcalfe D.D.
Characterization and comparison of human LAD1 mast cells with human LAD2 mast cells.
J. Allergy Clin. Immunol. 143 Suppl. 1:AB180-AB180(2019)

PubMed=31698677; DOI=10.3390/ijms20225520; PMCID=PMC6888318
Kirshenbaum A.S., Yin Y.-Z., Sundstrom J.B., Bandara G., Metcalfe D.D.
Description and characterization of a novel human mast cell line for scientific study.
Int. J. Mol. Sci. 20:5520.1-5520.9(2019)